Please select an option below to help us tailor your newsletter to best suit your content interests!
Advancements in ROS1-Positive Non-Small Cell Lung Cancer A recent article from CURE Today highlights the progress being made in targeted therapies for this rare subtype of lung cancer, which affects around 1-2% of patients. Our West family is proud to be at the forefront of this critical work, where Dr. Jason Porter and his team… Read more »
Our West family is so proud to support the annual Think Pink Memphis luncheon! <br> This weekend, Dr. Jason Porter and Dr. Carmel Verrier participated in the expert panel discussion, sharing information about: Screening guidelines Current treatment and surgical options Importance of physical therapy for pre- and post-surgery Resources available across the Mid-South <br> This… Read more »
🏆 20 West physicians have been named Castle Connolly Top Doctors 🏆 Castle Connolly’s Top Docs represent the ✨top 7%✨ of all U.S. practicing physicians! Selected through a rigorous process of peer nominations and thorough vetting by a physician-led research team, these doctors are truly top-notch healthcare providers. Their exceptional clinical care, specialty expertise, and… Read more »
Dr. Jason Porter details groundbreaking research for KRAS-mutant NSCLC during a Targeted Oncology Community Case Forum. 🎉 Explore the CodeBreaK 100 and CodeBreaK 200 studies, showing promising results and insights into new treatment strategies. Read more about the accelerated approval of new treatment options, and their impact on patients’ lives. Let’s revolutionize #LungCancer care together!… Read more »
Tuesday, September 19 at 5pm EST Join Dr. Jason Porter for a live, dynamic discussion about the critical role of biomarker testing and clinical trials in lung cancer! Dr. Porter will partner with Estelamari Rodriguez, MD, MPH from the University of Miami’s Sylvester Comprehensive Cancer Center and moderator Terric Conneran, Founder of KRAS Kickers, to… Read more »
Exciting News in Lung Cancer Treatment Dr. Jason Porter joins Dr. Maya Khalil, Dr. Brian Mitzman, and Dr. Rami Manochakian in discussing the strides made in improving patient outcomes with immunotherapy and targeted therapies for non-small cell lung cancer (NSCLC). The group talks about several new clinical trials demonstrating promising results for high… Read more »
This past weekend, Drs. Bradley Somer, Gregory Vidal, and Jason Porter hosted presentations at the Best of ASCO – Memphis Conference! This Post ASCO review showcased abstracts from highly rated presentations and the latest research in oncology education. Our physicians helped lead several discussions including: Dr. Jason Porter: – “Personalizing Treatment for Adult Patients with… Read more »
Our very own Dr. Jason Porter was a recent guest on the Research Evangelist Podcast. This podcast hosts weekly discussions with leaders in the lung cancer research community. Host, David Bjork, is a lung cancer survivor himself and patient advocate. He and Dr. Porter discuss molecularly-altered lung cancers, as well as those lung cancers with… Read more »
CONGRATULATIONS TO OUR TOP DOCTORS! Castle Connolly recently announced their 2023 #TopDoc picks, and 18 of our West physicians were selected. Of over 850,000 practicing providers in the U.S., our doctors were chosen though a rigorous 3rd party research process including study of their professional qualifications, education, appointments, leadership, reputation, and disciplinary history. Patients always… Read more »